SXL
AGN

Summit X LLC’s Allergan plc AGN Stock Holding History

Summit X LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,909
Closed -$387K – 259
2018
Q4 		$387K Sell
2,909
-218
-7% -$35.7K 0.22% 124
2018
Q3 		$600K Sell
3,127
-262
-8% -$48.1K 0.29% 84
2018
Q2 		$572K Buy
3,389
+435
+15% +$69.8K 0.32% 83
2018
Q1 		$500K Buy
2,954
+268
+10% +$45K 0.3% 90
2017
Q4 		$440K Buy
+2,686
New +$482K 0.28% 111
2017
Q3 		– Sell
-1,875
Closed -$455K – 196
2017
Q2 		$455K Buy
+1,875
New +$441K 0.32% 91

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Summit X LLC's AGN Position: Q1 2019 in Review

Summit X LLC sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 2,909 shares — an estimated $387K sold.

Summit X LLC first reported a position in AGN in Q2 2017 and held it in 6 quarters. The position peaked at $600K in Q3 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Summit X LLC reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Summit X LLC sold 2,909 Allergan plc shares in Q1 2019, an estimated $387K.
  • Summit X LLC first reported a position in Allergan plc in Q2 2017 and held it in 6 quarters.
  • Summit X LLC's Allergan plc position peaked at $600K in Q3 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Summit X LLC's 13F filing for Q1 2019, filed 13 May 2019.